Isotype-switched antibodies originating from tertiary lymphoid structures can antagonize ovarian cancer progression.
Saved in:
| Title: | Isotype-switched antibodies originating from tertiary lymphoid structures can antagonize ovarian cancer progression. |
|---|---|
| Authors: | Mandal G; Tumor Immunology and Immunotherapy, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, Maharashtra, India., Biswas S; Tumor Immunology and Immunotherapy, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, Maharashtra, India., Anadon CM; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Tamuli B; Tumor Immunology and Immunotherapy, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, Maharashtra, India., Chaurio RA; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Lopez-Bailon LU; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Plappert N; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Carrion-Estrada D; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Mine JA; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Lai CH; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Moreno AP; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA., Johnson J; Analytic Microscopy Core, Tampa, FL 33612, USA., Moran-Segura CM; Advanced Analytical and Digital Laboratory, Tampa, FL 33619, USA., Fang B; Proteomics and Metabolomics Core, Memphis, TN 38163, USA., Marchion D; Tissue Core, Tampa, FL 33612, USA., Chaudhary N; Flow Cytometry Core, Tampa, FL 33612, USA., Terry KL; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA., Sasamoto N; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Program in Epidemiology, Public Health Sciences Division, Fred Hutch Cancer Center, Seattle, WA 98109, USA., Townsend MK; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97201, USA., O'Brien J; Department of Medicine, Duke School of Medicine, Durham, NC 27710, USA., Antonia SJ; Department of Medicine, Duke School of Medicine, Durham, NC 27710, USA., Tworoger SS; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97201, USA., Yu X; Department of Biostatistics and Bioinformatics, Tampa, FL 33612, USA., Rodriguez PC; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA., Conejo-Garcia JR; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA. |
| Source: | IScience [iScience] 2026 Jul 10; Vol. 29 (8), pp. 116757. Date of Electronic Publication: 2026 Jul 10 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42472098 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Isotype-switched antibodies originating from tertiary lymphoid structures can antagonize ovarian cancer progression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mandal+G%22">Mandal G</searchLink>; Tumor Immunology and Immunotherapy, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Biswas+S%22">Biswas S</searchLink>; Tumor Immunology and Immunotherapy, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Anadon+CM%22">Anadon CM</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Tamuli+B%22">Tamuli B</searchLink>; Tumor Immunology and Immunotherapy, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, Maharashtra, India.; Homi Bhabha National Institute, Anushaktinagar, Mumbai 400094, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Chaurio+RA%22">Chaurio RA</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Lopez-Bailon+LU%22">Lopez-Bailon LU</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Plappert+N%22">Plappert N</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Carrion-Estrada+D%22">Carrion-Estrada D</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Mine+JA%22">Mine JA</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Lai+CH%22">Lai CH</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Moreno+AP%22">Moreno AP</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+J%22">Johnson J</searchLink>; Analytic Microscopy Core, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Moran-Segura+CM%22">Moran-Segura CM</searchLink>; Advanced Analytical and Digital Laboratory, Tampa, FL 33619, USA.<br /><searchLink fieldCode="AU" term="%22Fang+B%22">Fang B</searchLink>; Proteomics and Metabolomics Core, Memphis, TN 38163, USA.<br /><searchLink fieldCode="AU" term="%22Marchion+D%22">Marchion D</searchLink>; Tissue Core, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Chaudhary+N%22">Chaudhary N</searchLink>; Flow Cytometry Core, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Terry+KL%22">Terry KL</searchLink>; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Sasamoto+N%22">Sasamoto N</searchLink>; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Program in Epidemiology, Public Health Sciences Division, Fred Hutch Cancer Center, Seattle, WA 98109, USA.<br /><searchLink fieldCode="AU" term="%22Townsend+MK%22">Townsend MK</searchLink>; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97201, USA.<br /><searchLink fieldCode="AU" term="%22O'Brien+J%22">O'Brien J</searchLink>; Department of Medicine, Duke School of Medicine, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Antonia+SJ%22">Antonia SJ</searchLink>; Department of Medicine, Duke School of Medicine, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Tworoger+SS%22">Tworoger SS</searchLink>; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97201, USA.<br /><searchLink fieldCode="AU" term="%22Yu+X%22">Yu X</searchLink>; Department of Biostatistics and Bioinformatics, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+PC%22">Rodriguez PC</searchLink>; Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.<br /><searchLink fieldCode="AU" term="%22Conejo-Garcia+JR%22">Conejo-Garcia JR</searchLink>; Department of Integrative Immunobiology, Durham, NC 27710, USA.; Duke Cancer Institute, Durham, NC 27710, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101724038%22">IScience</searchLink> [iScience] 2026 Jul 10; Vol. 29 (8), pp. 116757. <i>Date of Electronic Publication: </i>2026 Jul 10 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101724038 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-0042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225890042%22">25890042 </searchLink><i>NLM ISO Abbreviation: </i>iScience <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42472098 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.isci.2026.116757 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 116757 Titles: – TitleFull: Isotype-switched antibodies originating from tertiary lymphoid structures can antagonize ovarian cancer progression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mandal G – PersonEntity: Name: NameFull: Biswas S – PersonEntity: Name: NameFull: Anadon CM – PersonEntity: Name: NameFull: Tamuli B – PersonEntity: Name: NameFull: Chaurio RA – PersonEntity: Name: NameFull: Lopez-Bailon LU – PersonEntity: Name: NameFull: Plappert N – PersonEntity: Name: NameFull: Carrion-Estrada D – PersonEntity: Name: NameFull: Mine JA – PersonEntity: Name: NameFull: Lai CH – PersonEntity: Name: NameFull: Moreno AP – PersonEntity: Name: NameFull: Johnson J – PersonEntity: Name: NameFull: Moran-Segura CM – PersonEntity: Name: NameFull: Fang B – PersonEntity: Name: NameFull: Marchion D – PersonEntity: Name: NameFull: Chaudhary N – PersonEntity: Name: NameFull: Terry KL – PersonEntity: Name: NameFull: Sasamoto N – PersonEntity: Name: NameFull: Townsend MK – PersonEntity: Name: NameFull: O'Brien J – PersonEntity: Name: NameFull: Antonia SJ – PersonEntity: Name: NameFull: Tworoger SS – PersonEntity: Name: NameFull: Yu X – PersonEntity: Name: NameFull: Rodriguez PC – PersonEntity: Name: NameFull: Conejo-Garcia JR IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: 2026 Jul 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2589-0042 Numbering: – Type: volume Value: 29 – Type: issue Value: 8 Titles: – TitleFull: IScience Type: main |
| ResultId | 1 |